Skip to main content
. Author manuscript; available in PMC: 2012 Aug 1.
Published in final edited form as: J Immunol. 2011 Jun 24;187(3):1506–1513. doi: 10.4049/jimmunol.1004142

Figure 1.

Figure 1

Effects of treatments on proteinuria onset and survival. Proteinuria (A) and survival (B) of Ad-IFNα treated NZB/W F1 mice. p values against Ad-IFNα treated controls: p = 0.0005 (proteinuria) and p = 0.0077 (survival), TACI-Ig treated mice; p = 0.0555 (proteinuria) and p = 0.0483 (survival), low dose CTLA4Ig treated mice; p<0.0001 (proteinuria and survival), high dose CTLA4Ig treated mice. Data are pooled from two representative experiments with a total of 15–27 mice per group.